EUVIMEDOpdag EUVIMED
Video/Audio

Isolating Ventricular Cardiomyocytes from a Mouse Model of Doxorubicin Cardiotoxicity

Yanyan Cheng, Tingting Jiang, Lei Xiao, Nanping Wang

Journal of Visualized Experiments · 2026

DOI: 10.3791/70411 ↗

At a glance

Video/Audio in Journal of Visualized Experiments, 2026. Written by Yanyan Cheng and 3 co-authors. Institution: Advanced Institute for Medical Sciences, Dalian Medical University; School of Basic Medical Sciences, Xi'an Jiaotong University. Major MEDLINE topics: Doxorubicin, Myocytes, Cardiac, Heart Ventricles, Antibiotics, Antineoplastic. 29 references.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Doxorubicin (DOX) is an effective chemotherapeutic drug whose clinical application is limited by progressive, dose-dependent cardiotoxicity that predominantly affects the ventricular myocardium. Studying cellular injury mechanisms in this context requires reliable isolation of adult cardiomyocytes, a process that is technically challenging in diseased or structurally fragile hearts. Here, we describe a simplified and reproducible Langendorff-free protocol for isolating functional ventricular cardiomyocytes from mice with DOX-induced cardiotoxicity. After establishing the DOX model in C57BL/6 mice, the heart is rapidly excised, and the aorta is clamped ex vivo. Non-recirculating antegrade perfusion is performed directly through the left ventricle using calcium-free and enzyme-containing buffers. Gentle mechanical dissociation of digested ventricular tissue yields individual cardiomyocytes, followed by controlled calcium reintroduction to restore calcium tolerance. This method provides high-quality, viable, rod-shaped cardiomyocytes that are compatible with downstream assays, including immunofluorescence, sarcomere organization analysis, apoptosis detection, and molecular signaling studies. By eliminating the need for specialized Langendorff perfusion equipment, this protocol offers an accessible, high-yield solution for laboratories investigating mechanisms of DOX-induced cardiac injury.

Subjects

MeSH terms (MEDLINE)

DoxorubicinMyocytes, CardiacHeart VentriclesAntibiotics, AntineoplasticAnimalsMiceMice, Inbred C57BLDisease Models, AnimalCardiotoxicityCytological Techniques

Substances

DoxorubicinAntibiotics, Antineoplastic

Authors and institutions

  • Advanced Institute for Medical Sciences, Dalian Medical University; School of Basic Medical Sciences, Xi'an Jiaotong University.
  • School of Basic Medical Sciences, Xi'an Jiaotong University; xiaolei0122@xjtu.edu.cn.
  • Advanced Institute for Medical Sciences, Dalian Medical University; East China Normal University Health Science Center; npwang@hsc.ecnu.edu.cn.

Cite

APA

Cheng, Y., Jiang, T., Xiao, L., & Wang, N. (2026). Isolating Ventricular Cardiomyocytes from a Mouse Model of Doxorubicin Cardiotoxicity. Journal of Visualized Experiments. https://doi.org/10.3791/70411

Vancouver

Cheng Y, Jiang T, Xiao L, Wang N. Isolating Ventricular Cardiomyocytes from a Mouse Model of Doxorubicin Cardiotoxicity. Journal of Visualized Experiments. 2026. doi:10.3791/70411

BibTeX
@article{Cheng2026,
  author = {Cheng, Yanyan and Jiang, Tingting and Xiao, Lei and Wang, Nanping},
  title = {Isolating Ventricular Cardiomyocytes from a Mouse Model of Doxorubicin Cardiotoxicity},
  journal = {Journal of Visualized Experiments},
  year = {2026},
  doi = {10.3791/70411}
}
Start for free →